Introduction
Nortriptyline (Allegron, Aventyl) and other drugs of the tricyclic group are now more widely prescribed than any other form of treatment for patients with depression, especially in domiciliary and out-patient practice. The results of treatment are, however, frequently poor (Porter, 1970) . Individual patients given a fixed dose of a tricyclic antidepressant drug achieve widely differing 'steady-state' plasma concentrations of the drug Braithwaite and Widdop, 1971 the rate of drug metabolism sometimes modified by concomitantly prescribed drugs which induce or inhibit metabolizing enzymes Alexanderson, Price-Evans and Sj6qvist, 1969; Gram and Fredricson-Over, 1972) . The relationship between plasma concentrations of these drugs and their antidepressant effects has recently been the subject of debate. Asberg et al. (1971, 1973) Each clinician was free to prescribe the dose of nortriptyline he thought appropriate and was also free to assess patients at follow-up in whatever way he wished and to record his opinion of their progress at any stage, once they had been taking nortriptyline for at least 2 weeks.
At the time of assessment for the purposes of this study the attending clinician recorded his opinion of each patient's progress with respect to relief of symptoms of depression as 'satisfactory' or 'unsatisfactory'. He also recorded any decision to change the treatment. At the same time blood was collected for nortriptyline estimation.
A standard record form was used and upon this were recorded each patient's age, weight, dose of nortriptyline prescribed, any other therapy given, side effects reported, opinion about progress and reason for withdrawal where appropriate.
Ten millilitres of blood were collected into lithium heparin tubes, centrifuged at the respective hospital laboratories for 5 min at 3000 rev/min, aspirated into fresh tubes and despatched to the Poisons Unit in London where the samples were deep frozen until analysed. It had been previously demonstrated (Braithwaite and Widdop, 1971 ) and was again confirmed that nortriptyline contained in plasma samples did not decline even after prolonged storage at room temperature.
Plasma nortriptyline assays were carried out by a specific gas-chromatographic method (Braithwaite and Widdop, 1971) in ignorance of the clinical data from the patients. Spot checks of urine for the presence of other drugs were also carried out.
Results
Detailed results for the forty-five patients in the study are presented in Table 1 . Thirty-one of the patients were women, average age 41, and fourteen were men, average age 38, the age range of the entire group being from 20 to 77 years.
Nortriptyline was prescribed in daily doses which varied from 55-200 mg, almost half the patients being given substantially larger doses than the 75-100 mg daily advocated by the manufacturer.
Clinical assessment and blood collection were carried out at various times after the patients began to take nortriptyline, from 14 to 56 days. Thirty patients were considered at the time of blood collection to have been making 'satisfactory' progress. Of the patients in the 'satisfactory' group, one had her dose of nortriptyline reduced, the others continuing as before. Only in one instance was 'unsatisfactory' progress the result of adverse reaction in this patient and no change in dose was ordered. The other fourteen were all judged to be gaining less benefit from nortriptyline than was expected and changes in the antidepressant regimen were made for thirteen of these patients. The drug was withdrawn in six instances, the dose increased in five, and ECT prescribed in addition to nortriptyline in two.
Plasma nortriptyline concentrations in this group of patients ranged from 44 ng/ml to 305 ng/ml (Fig.  1) .
Barbiturate, which had not been prescribed at the clinic, was detected in the urine of three patients, one of whom was the patient whose 'unsatisfactory' response to treatment was attributed to adverse reaction and whose plasma nortriptyline concentration was less than 20 ng/ml.
Dose and plasma concentration of nortriptyline
The relationship between the daily dose (mg/kg) and plasma concentration (ng/ml) is shown in Fig. 2 for the forty-one patients for whom the complete data are available. Plasma concentrations tend to be higher among the patients given the larger daily doses but much scatter is apparent.
Clinical response, dose andplasma concentration of nortriptyline
The lack of an optimum dose (mg/kg) of nortriptyline is demonstrated in Fig. 3 .
The relationship of plasma nortriptyline concentration to clinical response is shown in Fig. 4 . Again there is no evidence of an optimum plasma nortriptyline concentration, patients showing 'unsatisfactory' response and 'satisfactory' response to treatment over the same range of plasma concentrations, from less than 20 ng/ml to over 300 ng/ml.
Effect of observers
Five of the psychiatrists taking part in this study personally supervised at least seven patients ( 
Discussion
The wide range of plasma nortriptyline concentrations observed in our patients given similar doses of nortriptyline confirms previously published findings, as also does the lack of correlation between dosage and therapeutic response (Asberg et al., 1971 ).
We did not find a correlation between plasma nortriptyline concentrations and a 'satisfactory' therapeutic response. This is in general agreement with the findings of Burrows and his colleagues (1972) , who had given a standard dose of 150 mg of nortriptyline daily to thirty-two patients for at least 4 weeks. Our findings conflict with those of Asberg et al. (1971) and Kragh-Sorensen et al. (1973) showing a correlation between plasma nortriptyline concentrations and therapeutic response. Our results also conflict with the findings for amitriptyline obtained by Braithwaite et al. (1972) where a highly significant positive correlation between plasma levels and therapeutic response was obtained. However, for several reasons our respective studies are not strictly comparable.
We assessed patients on a simple 'all or none' principle on a single occasion whereas in the other studies rating scales for depression were used repeatedly in individual subjects. We 
